5 Bladder Cancer Clinical Trials in Myrtle Beach, SC (2026)

Q: How do I join a clinical trial in Myrtle Beach?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Myrtle Beach research site will contact you.

Recruiting Bladder Cancer Studies in Myrtle Beach

NCT07480356Recruiting

Efficacy and Safety of Intravesical TARA-002 Compared With Investigator's Choice of Intravesical Chemotherapy in Participants With BCG-naïve High-grade Non-muscle Invasive Bladder Cancer

The goal of this clinical trial is to learn if TARA-002 can treat high-grade non-muscle invasive bladder cancer (NMIBC) in BCG-naïve adults 18 years of age or older. The main questions it aims to ans...

Myrtle Beach, SCPHASE3284 participantsProtara Therapeutics

View Study Details

NCT07475806Recruiting

A Study to Find Out if Enfortumab Vedotin Given With Pembrolizumab Helps People With Muscle-invasive Bladder Cancer Keep Their Bladder

People with a type of bladder cancer called muscle-invasive bladder cancer have cancer that has spread into the muscle wall of the bladder. The standard treatment is to have chemotherapy, followed by ...

Myrtle Beach, SCPHASE2240 participantsAstellas Pharma Global Development, Inc.

View Study Details

NCT03945162Recruiting

Intravesical Photodynamic Therapy ("PDT") in BCG-Unresponsive/Intolerant Non-Muscle Invasive Bladder Cancer ("NMIBC") Patients

This is a phase II, open-label, single-arm, multi-center Study conducted in Canada and the United States. Patients with NMIBC CIS (with or without resected papillary disease (Ta, T1)) that are conside...

Myrtle Beach, SCPHASE290 participantsTheralase® Technologies Inc.

View Study Details

NCT05483868Recruiting

A Phase 1, Open-label Trial of Belzupacap Sarotalocan (AU-011) in Bladder Cancer

The main objectives of this study are to determine the feasibility and safety of Belzupacap Sarotalocan (AU-011, bel-sar) treatment of bladder cancer utilizing focal injections with or without laser a...

Myrtle Beach, SCPHASE155 participantsAura Biosciences

View Study Details

NCT07222488Recruiting

A Clinical Study of MK-3120 in People With Bladder Cancer (MK-3120-003)

Researchers are looking for new ways to treat high-risk non-muscle invasive bladder cancer (HR NMIBC). NMIBC is cancer in the tissue that lines the inside of the bladder and has not spread to the blad...

Myrtle Beach, SCPHASE145 participantsMerck Sharp & Dohme LLC

View Study Details

About Bladder Cancer Clinical Trials in Myrtle Beach

Bladder cancer occurs in the tissues of the bladder and is one of the most common cancers. It has a high recurrence rate, requiring ongoing monitoring. Treatments include surgery, intravesical therapy, chemotherapy, and immunotherapy.

There are currently 5 bladder cancer clinical trials recruiting participants in Myrtle Beach, SC. These studies are seeking a combined 714 participants. Research is being sponsored by Protara Therapeutics, Astellas Pharma Global Development, Inc., Theralase® Technologies Inc. and 2 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Bladder Cancer Clinical Trials in Myrtle Beach — FAQ

Are there bladder cancer clinical trials in Myrtle Beach?

Yes, there are 5 bladder cancer clinical trials currently recruiting in Myrtle Beach, SC. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Myrtle Beach?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Myrtle Beach research site will contact you about next steps.

Are clinical trials in Myrtle Beach free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Myrtle Beach studies also compensate for your time and travel.

What bladder cancer treatments are being tested?

The 5 active trials in Myrtle Beach are testing new therapies including novel drugs, biologics, and treatment approaches for bladder cancer.

Data updated July 22, 2026 from ClinicalTrials.gov